LRG1 anticorps

N° du produit ABIN2191876

Cet anticorps Souris Monoclonal détecte spécifiquement LRG1 dans WB et IA. Il présente une réactivité avec des échantillons de Humain.Il a été cité dans 1 publication.

Aperçu rapide pour LRG1 anticorps (ABIN2191876)

Antigène: LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp LRG1 est non-conjugé

Application: Western Blotting (WB), Immunoassay (IA)

Clone: 2F5-A2

Détail du produit anti-LRG1 anticorps

Stérilité: 0.2 μm filtered

Information d'application

Indications d'application: and determine their own optimal dilutions. The typical starting working dilution is 1:50.

Restrictions: For Research Use only

Stockage

Buffer: PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Date de péremption: 12 months

Références pour anticorps anti-LRG1 (ABIN2191876)

Codina, Vanasse, Kelekar, Vezys, Jemmerson: "Cytochrome c-induced lymphocyte death from the outside in: inhibition by serum leucine-rich alpha-2-glycoprotein-1." dans: Apoptosis : an international journal on programmed cell death, Vol. 15, Issue 2, pp. 139-52, (2010) (PubMed).

Détails sur LRG1

Antigène: LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))

Autre désignation: Leucine-Rich alpha-2-Glycoprotein

Sujet: The monoclonal antibody recognizes leucine-rich alpha-2-glycoprotein (LRG), a member of the leucine- rich repeat family. LRG is a plasma protein of approximately 50 kDa. LRG consists of 312 amino acids. It has 1 galactosamine and 4 glucosamine oliogosacharides attached and has 2 intrachain disulfide bonds. Leucine comprises 66 of the 312 amino acids, and LRG contains at least eight 24-amino acid leucine-rich repeats. The consensus of these residues, termed leucine-rich repeats (LRR), has been identified as an LRR-containing domain. The primary function of LRRs is to provide versatile structural framework of the formation of protein-protein interactions. LRG is expressed during granulocyte differentiation. Although several family members of the leucine-rich repeat family have been shown to be involved in signal transduction, protein-protein interaction, or cell adhesion and development, a function for LRG remains elusive. LRG has been reported as a biomarker for certain diseases including microbial infections and cancer. LRG can be detected in human neutrophils and progenitor cells, but not in peripheral blood mononuclear cells. The monoclonal antibody 2F5.A2 can be used for immuno purification of human LRG. Aliases Leucine-rich alpha-2-glycoprotein, LRG Immunogen Human LRG, covalently coupled to hemocyanin using glutaraldehyde

Pathways: Brown Fat Cell Differentiation